Diatreme Resources Limited Logo

Diatreme Resources Limited

DRX.AX

(1.8)
Stock Price

0,02 AUD

9% ROA

17.96% ROE

15.56x PER

Market Cap.

85.784.480,00 AUD

2.92% DER

0% Yield

5001.23% NPM

Diatreme Resources Limited Stock Analysis

Diatreme Resources Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Diatreme Resources Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (3%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 ROE

ROE in an average range (11.92%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (9%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (1.47x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Diatreme Resources Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Diatreme Resources Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Diatreme Resources Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Diatreme Resources Limited Revenue
Year Revenue Growth
2005 2.822
2006 17.837 84.18%
2007 88.672 79.88%
2008 94.808 6.47%
2009 0 0%
2010 0 0%
2011 251.585 100%
2012 123.347 -103.97%
2013 168.534 26.81%
2014 231.673 27.25%
2015 135.415 -71.08%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 697 100%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Diatreme Resources Limited Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Diatreme Resources Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 155.589
2006 647.504 75.97%
2007 939.097 31.05%
2008 1.945.287 51.72%
2009 2.085.296 6.71%
2010 1.699.366 -22.71%
2011 2.169.553 21.67%
2012 2.170.396 0.04%
2013 2.015.736 -7.67%
2014 2.208.847 8.74%
2015 1.500.150 -47.24%
2016 1.204.940 -24.5%
2017 1.056.354 -14.07%
2018 1.106.586 4.54%
2019 1.278.579 13.45%
2020 1.226.596 -4.24%
2021 1.759.469 30.29%
2022 2.930.269 39.96%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Diatreme Resources Limited EBITDA
Year EBITDA Growth
2005 -555.585
2006 -1.210.705 54.11%
2007 -1.413.705 14.36%
2008 -2.335.730 39.47%
2009 -2.490.298 6.21%
2010 -3.889.785 35.98%
2011 -4.439.795 12.39%
2012 -5.012.185 11.42%
2013 -5.084.566 1.42%
2014 -7.948.010 36.03%
2015 -3.766.162 -111.04%
2016 -1.551.728 -142.71%
2017 -1.135.789 -36.62%
2018 -2.488.936 54.37%
2019 -1.096.792 -126.93%
2020 -795.887 -37.81%
2021 -1.937.766 58.93%
2022 5.201.719 137.25%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Diatreme Resources Limited Gross Profit
Year Gross Profit Growth
2005 2.822
2006 17.837 84.18%
2007 88.672 79.88%
2008 94.808 6.47%
2009 0 0%
2010 0 0%
2011 251.585 100%
2012 123.347 -103.97%
2013 168.534 26.81%
2014 231.673 27.25%
2015 135.415 -71.08%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 697 100%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Diatreme Resources Limited Net Profit
Year Net Profit Growth
2005 -1.289.927
2006 -932.383 -38.35%
2007 704.305 232.38%
2008 -2.439.409 128.87%
2009 -2.739.545 10.96%
2010 -4.000.451 31.52%
2011 -4.377.262 8.61%
2012 -4.908.468 10.82%
2013 -4.797.128 -2.32%
2014 -7.252.709 33.86%
2015 -3.877.435 -87.05%
2016 -1.850.962 -109.48%
2017 -1.418.526 -30.48%
2018 -2.749.202 48.4%
2019 -1.574.993 -74.55%
2020 -1.820.873 13.5%
2021 -2.275.840 19.99%
2022 4.978.378 145.71%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Diatreme Resources Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Diatreme Resources Limited Free Cashflow
Year Free Cashflow Growth
2005 -5.871
2006 -75.036 92.18%
2007 -216.438 65.33%
2008 -858.886 74.8%
2009 -673.527 -27.52%
2010 -3.136.708 78.53%
2011 -2.950.989 -6.29%
2012 -3.209.875 8.07%
2013 -3.609.725 11.08%
2014 -3.141.857 -14.89%
2015 -684.270 -359.15%
2016 -711.261 3.79%
2017 -528.449 -34.59%
2018 -1.907.599 72.3%
2019 -532.210 -258.43%
2020 -3.102.277 82.84%
2021 -6.551.847 52.65%
2022 -1.913.105 -242.47%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Diatreme Resources Limited Operating Cashflow
Year Operating Cashflow Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 5.149.656 100%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Diatreme Resources Limited Capital Expenditure
Year Capital Expenditure Growth
2005 5.871
2006 75.036 92.18%
2007 216.438 65.33%
2008 858.886 74.8%
2009 673.527 -27.52%
2010 3.136.708 78.53%
2011 2.950.989 -6.29%
2012 3.209.875 8.07%
2013 3.609.725 11.08%
2014 3.141.857 -14.89%
2015 684.270 -359.15%
2016 711.261 3.79%
2017 528.449 -34.59%
2018 1.907.599 72.3%
2019 532.210 -258.43%
2020 3.102.277 82.84%
2021 6.551.847 52.65%
2022 7.062.761 7.23%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Diatreme Resources Limited Equity
Year Equity Growth
2005 7.558.656
2006 9.765.100 22.6%
2007 18.715.190 47.82%
2008 16.531.223 -13.21%
2009 21.541.058 23.26%
2010 22.137.182 2.69%
2011 24.291.675 8.87%
2012 22.619.717 -7.39%
2013 20.597.805 -9.82%
2014 14.780.969 -39.35%
2015 11.922.769 -23.97%
2016 10.863.173 -9.75%
2017 12.053.640 9.88%
2018 13.902.462 13.3%
2019 17.412.417 20.16%
2020 23.220.816 25.01%
2021 30.761.347 24.51%
2022 52.746.307 41.68%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Diatreme Resources Limited Assets
Year Assets Growth
2005 8.118.900
2006 10.369.721 21.71%
2007 20.191.141 48.64%
2008 18.229.672 -10.76%
2009 22.040.101 17.29%
2010 22.657.772 2.73%
2011 24.859.782 8.86%
2012 23.064.562 -7.78%
2013 22.102.096 -4.35%
2014 15.237.360 -45.05%
2015 13.545.426 -12.49%
2016 14.060.241 3.66%
2017 14.441.405 2.64%
2018 17.214.636 16.11%
2019 19.881.539 13.41%
2020 25.622.323 22.41%
2021 33.135.877 22.67%
2022 55.333.890 40.12%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Diatreme Resources Limited Liabilities
Year Liabilities Growth
2005 560.244
2006 204.404 -174.09%
2007 378.648 46.02%
2008 674.468 43.86%
2009 499.043 -35.15%
2010 520.590 4.14%
2011 568.107 8.36%
2012 444.845 -27.71%
2013 1.504.291 70.43%
2014 456.391 -229.61%
2015 1.622.657 71.87%
2016 3.197.068 49.25%
2017 2.387.765 -33.89%
2018 3.312.174 27.91%
2019 2.469.122 -34.14%
2020 2.401.507 -2.82%
2021 2.374.530 -1.14%
2022 2.587.583 8.23%

Diatreme Resources Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
15.56x
Price To Sales Ratio
123076.73x
POCF Ratio
15.04
PFCF Ratio
-44.84
Price to Book Ratio
1.47
EV to Sales
105716.98
EV Over EBITDA
14.17
EV to Operating CashFlow
14.31
EV to FreeCashFlow
-38.52
Earnings Yield
0.06
FreeCashFlow Yield
-0.02
Market Cap
0,09 Bil.
Enterprise Value
0,07 Bil.
Graham Number
0.02
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
1.03
ROE
0.12
Return On Assets
0.16
Return On Capital Employed
-0.06
Net Income per EBT
-2.99
EBT Per Ebit
0.97
Ebit per Revenue
-17.27
Effective Tax Rate
3.99

Margins

Sales, General, & Administrative to Revenue
4204.12
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.03
Operating Profit Margin
-17.27
Pretax Profit Margin
-16.71
Net Profit Margin
50.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
-0
Capex to Operating CashFlow
-1.37
Capex to Revenue
-10133.09
Capex to Depreciation
-41.24
Return on Invested Capital
0.09
Return on Tangible Assets
0.09
Days Sales Outstanding
294819.45
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,02
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.02
Interest Debt per Share
0
Debt to Equity
0.03
Debt to Assets
0.03
Net Debt to EBITDA
-2.33
Current Ratio
14.09
Tangible Asset Value
0,05 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.03
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Diatreme Resources Limited Dividends
Year Dividends Growth

Diatreme Resources Limited Profile

About Diatreme Resources Limited

Diatreme Resources Limited engages in the exploration of heavy mineral sands, copper, gold, and base metals in Australia. The company's flagship property is the Galalar Silica Sand project located in North Queensland. Diatreme Resources Limited was incorporated in 1993 and is based in Coorparoo, Australia.

CEO
Mr. Neil John McIntyre MAICD,
Employee
5
Address
55-61 Holdsworth Street
Coorparoo, 4151

Diatreme Resources Limited Executives & BODs

Diatreme Resources Limited Executives & BODs
# Name Age
1 Mr. Tuan Quy Do CA, BCom.
Chief Financial Officer, Financial Controller & Company Secretary
70
2 Mr. Neil John McIntyre MAICD, MBE
Chief Executive Officer
70
3 Mr. Neil MacKenzie-Forbes
Chief Geologist
70

Diatreme Resources Limited Competitors

DGR Global Limited Logo
DGR Global Limited

DGR.AX

(1.2)
Dart Mining NL Logo
Dart Mining NL

DTM.AX

(1.5)
VRX Silica Limited Logo
VRX Silica Limited

VRX.AX

(1.0)